|
IL-1α (mean ± SD) n = 5
|
Protein (intensity)
|
ΔCt: mRNA
|
2-ΔΔCt
|
|---|
|
Primary EC (control)
|
4678.6 ± 473
|
14.3 ± 0.4
| |
|
RL-952
|
4948.3 ± 167
|
14.4 ± 0.6
|
1.1
|
|
TOV-112D
|
5217.1 ± 391
|
13.6 ± 0.1
|
1.3
|
|
TOV-21G
|
11320.1 ± 391*
|
13.2 ± 0.2
|
1.9*
|
|
OV-90
|
3897.6 ± 590
|
15 ± 0.6
|
0.8
|
|
IL-1β (mean ± SD) n = 5
| | | |
|
Primary EC (control)
| |
11.4 ± 0.6
| |
|
RL-952
| |
10.8 ± 0.4
|
1.3
|
|
TOV-112D
| |
10.0 ± 0.3
|
2.0*
|
|
TOV-21G
| |
10.7 ± 0.3
|
1.4
|
|
OV-90
| |
9.9 ± 0.2
|
2.2*
|
|
IL-1RA (mean ± SD) n = 5
| | | |
|
Primary EC (control)
|
6921.1 ± 611
|
16.8 ± 0.7
| |
|
RL-952
|
8391.3 ± 241
|
15.9 ± 0.1
|
1.2
|
|
TOV-112D
|
2101.6 ± 352*
|
18.9 ± 0.6
|
0.2*
|
|
TOV-21G
|
8798.1 ± 571*
|
16.1 ± 0.4
|
1.3
|
|
OV-90
|
13251.6 ± 495
|
15.9 ± 0.3
|
1.4
|
- 2-ΔΔCt: fold differences of mRNA expression.
- * P < 0.05, comparison to control (primary endometrial cells).
